![John Shannon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Shannon
Vorstandsvorsitzender bei
XERIS BIOPHARMA HOLDINGS, INC.
Vermögen: 12 Mio $ am 30.06.2026
Profil
John Patrick Shannon is currently Chairman & Chief Executive Officer at Xeris Biopharma Holdings, Inc. since 2026.
Former positions include Chief Executive Officer & Director at Catheter Connections, Inc. from 2015 to 2016; Executive Director-Cardiovascular Global at Viatris Holdings LLC from 1991 to 2001; GM-Global Hemophilia & Commercial Excellence at Baxter Healthcare Corp.
from 2001 to 2011; President & Chief Operating Officer at Xeris Pharmaceuticals, Inc. from 2020 to 2021; Head-Sales Operations, Marketing & Strategic at Bock Pharmacal Co.; Vice President & General Manager at Baxter BioScience Corp.
from 2002 to 2012; Vice President-Marketing at Caremark LLC; and Chief Commercial Officer at Durata Therapeutics, Inc. from 2012 to 2014.
Education includes undergraduate studies at Western Illinois University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2026 | 1 507 143 ( 0,87 % ) | 12 Mio $ | 30.06.2026 |
Aktive Positionen von John Shannon
| Unternehmen | Position | Beginn |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Vorstandsvorsitzender | 01.08.2024 |
Ehemalige bekannte Positionen von John Shannon
| Unternehmen | Position | Ende |
|---|---|---|
Catheter Connections, Inc.
 Catheter Connections, Inc. Medical SpecialtiesHealth Technology Develops vascular access products | Vorstandsvorsitzender | 01.01.2016 |
| DURATA THERAPEUTICS INC | Corporate Officer/Principal | 01.11.2014 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Corporate Officer/Principal | 01.01.2012 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | 01.01.2011 |
Viatris Holdings LLC
 Viatris Holdings LLC Pharmaceuticals: MajorHealth Technology Produces noncommunicable and infectious diseases therapeutic medicines | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von John Shannon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Develops vascular access products | Health Technology |
Bock Pharmacal Co.
 Bock Pharmacal Co. Miscellaneous Commercial ServicesCommercial Services Wholesale pharmaceutical packaging and distribution | Commercial Services |
Western Illinois University
 Western Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Viatris Holdings LLC
Viatris Holdings LLC Pharmaceuticals: MajorHealth Technology Produces noncommunicable and infectious diseases therapeutic medicines | Health Technology |
Caremark LLC | |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
